Bayer

By Dave Muoio April 12, 2018
ActiGraph activity monitors and a mobile app from Clinical Ink are are at the heart of a newly announced pilot study backed by Bayer, according to a statement released today by ActiGraph. The ongoing study is evaluating how these digital products and a Bluetooth-enabled weight scale are perceived by patients, and the feasibility of implementing such devices in future clinical trials run by the...
By Jonah Comstock March 14, 2018
At HIMSS last week, Samsung announced a partnership with Travelers Insurance, Cedars-Sinai Medical Center, Bayer, and AppliedVR around using virtual reality for pain management. Samsung and Travelers will fund a 16-month study of between 90 and 140 patients, conducted at Cedars using technology from Samsung, Bayer, and AppliedVR. "We just completed a randomized control trial that shows you can...
By Jonah Comstock October 4, 2017
After running its G4A (Grants4Apps) program in Berlin for five years, Bayer is launching a new accelerator program in the United States, the company announced at Health 2.0’s Fall Conference in Santa Clara, California yesterday. While the plans for the new venture, dubbed G4A Generator, are still being developed, Barton Warner, VP of strategy and portfolio management at Bayer, did share some...
By Jonah Comstock June 16, 2017
Bayer recently received FDA approval for a connected auto-injector for relapsing-remitting multiple sclerosis medication and companion app. The device is called the Betaconnect Electronic Autoinjector and the app, due out in July, is myBetaApp. The Whippany, New Jersey-based pharma company didn't clear the app and device through the 510(k) medical device pathway; instead the agency approved a...
By Jonah Comstock September 27, 2016
The future of pharma is going to involve some major culture shifts for a business that has long been focused on slow development cycles, proprietary molecules, and close-held secrets. That’s the word from representatives from Bayer, Boehringer Ingelheim, Healthware International and BTG, a group that ran the gamut from small to big pharma at yesterday’s Pharma Roundtable onsite at Health 2.0 in...
By Jonah Comstock May 14, 2015
A London hospital is the latest to put the Apple Watch to use within its walls, this time to improve medication management and adherence for cancer patients undergoing chemotherapy. According to a report from Wareable, King's College Hospital will be the first to pilot an app from Medopad, a British company that also makes tablet-based mobile health technology. "Cancer treatment is a challenging...
By Jonah Comstock January 13, 2015
Norwalk, Connecticut-based medication adherence platform company HealthPrize says it has succeeded in raising medication adherence an average of 54 percent across a series of pharma-sponsored pilot programs for various medical conditions, with sample sizes ranging from 250 to more than 7,000. That's a 54 percent increase in the mean total number of prescription fills per patient. HealthPrize,...
By Jonah Comstock October 27, 2014
Pharmaceutical companies have a lot of apps in the market, and have been making apps for a long time, but their apps aren't seeing downloads and usage on par with the apps from other industries. That's the conclusion of a new report from Research2Guidance (R2G), which analyzed more than 725 apps from 11 pharma companies. According to R2G, the top pharma companies have 65 apps in the Apple and...
By Jonah Comstock January 22, 2013
Healthbox CEO Nina Nashif speaks at the Innovation Day in London. Just a year after launching its first class in Chicago, Healthbox held a demo day in London to showcase its first European class. The seven startups, representing four countries, which were announced in October 2012, have now completed Healthbox's three-month accelerator course. They were chosen out of an initial pool of about 200...
By Brian Dolan April 12, 2010
Bayer is bringing the Nintendo DS enabled blood glucose meter, Didget, to the US next month, according to a report in BusinessWeek. Inventor and entrepreneur Paul Wessel wanted his diabetic 4-year-old son, Luke, to stop hiding his glucose meter, so he found a way to pair one of Luke's treasured possessions, his Nintendo DS, with his least favorite. German healthcare company Bayer purchased Wessel...
https://www.steroid-pharm.com

source steroid-pharm.com

http://steroid-pharm.com